The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in

Christy L Avery1, Laura R Loehr, Christopher Baggett

  • 1Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514, USA. christy_avery@unc.edu

Insights

Reducing diabetes prevalence by 5% could prevent 30,000 heart failure cases annually in the U.S. This highlights the significant impact of managing modifiable risk factors on heart failure incidence.

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Chronic disease management

Background:

  • Heart failure (HF) is a significant public health concern, characterized by high morbidity, mortality, and healthcare costs.
  • While HF is prevalent, the population-level impact of modifiable risk factors remains under-evaluated.
  • Investigating modifiable risk factors is crucial for developing effective prevention strategies for heart failure.

Purpose of the Study:

  • To estimate the population burden of heart failure (HF).
  • To assess the influence of five modifiable risk factors on HF incidence.
  • To quantify the potential reduction in HF incidence through risk factor modification.

Main Methods:

  • Analysis of 14,709 participants from the Atherosclerosis Risk in Communities (ARIC) study.
  • Estimation of incidence rate differences (IRD) for associations between smoking, diabetes, high LDL, hypertension, obesity, and HF.
  • Calculation of potential impact fractions to model HF incidence reduction with a 5% decrease in risk factor prevalence.

Main Results:

  • Over 17.6 years, 1 in 3 African American and 1 in 4 Caucasian participants were hospitalized for heart failure.
  • Diabetes exhibited the largest IRD, contributing to 1,058/100,000 person-years in African Americans and 660/100,000 in Caucasians.
  • A 5% reduction in diabetes prevalence could prevent ~30,000 heart failure cases annually in the U.S. population.

Conclusions:

  • Modest reductions in modifiable risk factors, particularly diabetes, can significantly lower heart failure incidence.
  • Targeting modifiable risk factors offers a viable strategy for reducing the population burden of heart failure.
  • Public health interventions focused on risk factor management are essential for preventing heart failure.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...